Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Prareduct

Known as: Mevalotin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Mevalotin containing pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, is the brand medicine and well… Expand
2008
2008
OBJECTIVES This paper illustrates a high speed clinical data retrieving system, from 10 years of data of operating hospital… Expand
2005
2005
A quantitative method was developed and validated for rapid and sensitive analysis of pravastatin and R-416, the main metabolite… Expand
2004
2004
0006-2979/01/6610-1187$25.00 ©2001 MAIK “Nauka/Interperiodica” This book consists of 30 chapters written by an international… Expand
2003
2003
Oral rapid disintegrating tablets are taken in an epochal dosage form which makes drug ingestion less trou-blesome for patients… Expand
1998
1998
In the present study it was examined if the common marmoset was susceptible to pravastatin (CAS 81131-70-6, CS 514, Mevalotin… Expand
1996
1996
During the last years our knowledge of factors that contribute to development and progression of atherosclerosis has increased… Expand
Review
1996
Review
1996
Research and development of new antifungal therapeutics continues to be stimulated by significant and growing medical needs as… Expand
1995
1995
There is no consensus on lipids and restenosis after percutaneous transluminal coronary angioplasty (PTCA). We evaluated whether… Expand
1993
1993
An automatic feeding process for microbial hydroxylation of ML236B sodium salt (ML‐236B Na; compactin) by Streptomyces… Expand